Cardiome initiated by Rodman & Renshaw at market outperform

Cardiome Pharma Corp. coverage was initiated by Rodman & Renshaw analyst Michael King at a market outperform rating with a price target on the stock of $10 per share. Cardiome shares Friday were up $0.11, or 1.49%, at $7.51 on volume of 248,896 shares versus the three-month running average of 203,205 shares.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.